Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method-Reference-Cited by-全球学者库

Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method

Published:2015-11-13 Issue:11 Volume:10 Page:e0142135
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chao Wan-Ru,Lee Ming-Yung,Ruan Alexandra,Sheng Huang Pin,Hsu Jeng-Dong,Han Chih-Ping,Koo Chiew-Loon

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference15 articles.

1. Roche. Herceptin (Trastuzumab), CAS-180288-69-1. Amendment: 13 Mar 2015, Available: http://www.roche-australia.com/content/dam/internet/corporate/roche/en_AU/files/oncology/herceptin-pi.pdf. Accessed 2015 Oct 22.

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;YJ Bang;Lancet,2010

3. HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer;WR Chao;Human Pathology,2014

4. The measurement of observer agreement for categorical data;JR Landis;Biometrics,1977

5. Check W. IHC, FISH still sharing HER2 spotlight. CAP Today. 2005; 19:1, 40, 42 passim, Available: http://www.captodayonline.com/Archives/cover_stories/0805HER2.html. Accessed 2015 Oct 22.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AlGaN/GaN HEMT Based Biosensor for Detection of the HER2 Antigen Spiked in Human Serum;IEEE Transactions on Electron Devices;2022-08

2. Comparing the 2017 ASCO/CAP guideline for gastroesophageal adenocarcinoma surgical specimen to the 2018 ASCO/CAP guideline for breast cancer in assessing the HER2 status in primary mucinous ovarian carcinoma;Virchows Archiv;2022-02-28

3. High sensitivity label-free detection of HER2 using an Al–GaN/GaN high electron mobility transistor-based biosensor;Lab on a Chip;2022

4. 2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A – Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B – Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine);Bioanalysis;2021-03

5. Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications;European Journal of Cancer Supplements;2020-08